- Investing Ideas
- /
- Top Dividend Stocks
Top Chinese (SSE) Pharmaceuticals & Biotech Dividend Stocks
UPDATED Jul 03, 2022
What are the best Chinese (SSE) Pharmaceuticals & Biotech Dividend Stocks?
According to our Simply Wall St analysis these are the best Chinese Pharmaceuticals & Biotech dividend companies. We look for companies with high quality dividends and healthy balance sheets to find the top Dividend Stocks.
Our criteria to find Top Dividend Companies
High Yield
- Companies with a high dividend yield are more attractive due to the higher expected income for each dollar invested.
- Yields vary between markets, so we focus on the top dividend payers in each market.
What do we look for?
- Is the yield in the top 25% of the market's dividend payers.
Consistent Dividends
- Companies with a strong track record of paying a consistent and growing dividend are the most attractive.
- If the dividend has been cut substantially in the past, then it's difficult to be confident about future payments.
What do we look for?
- Has the dividend been stable over the last 10 years.
- Has the dividend grown over the last 10 years.
Dividend Cover
- Ideally the company doesn't pay out all of its earnings, neglecting future growth.
- If a company is unable to afford its dividend, then it will probably lead to a dividend cut and share price erosion.
What do we look for?
- Are dividends covered by earnings.
- Are dividends forecast to be covered by earnings in the future.
Healthy Balance Sheet
- Investors want to make sure the company is positioned to cover its debts. Repayments on debt typically take priority over shareholder return initiatives.
What do we look for?
- Does the company have a manageable level of debt.
- Is the company able to cover its interest repayments.
3 companies meet this criteria in the Chinese market
Dividend Criteria
Stable Dividend
Growing Dividend
Notable Dividend
High Dividend: 300009's dividend (1.9%) is low compared to the top 25% of dividend payers in the CN market (1.92%).
Future Dividend Coverage
Earnings Coverage
Rewards
Trading at 67.3% below our estimate of its fair value
Earnings are forecast to grow 40.23% per year
Risks
Profit margins (11.5%) are lower than last year (21.5%)
Large one-off items impacting financial results
Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China.
Dividend Criteria
Earnings Coverage
Growing Dividend
Notable Dividend
High Dividend: 000423's dividend (1.78%) is low compared to the top 25% of dividend payers in the CN market (1.92%).
Future Dividend Coverage
Stable Dividend
Rewards
Trading at 69.1% below our estimate of its fair value
Earnings are forecast to grow 33.59% per year
Earnings grew by 161.4% over the past year
Risks
No risks detected for 423 from our risks checks.
Dividend Criteria
Earnings Coverage
Growing Dividend
Notable Dividend
High Dividend: 002603's dividend (1.19%) is low compared to the top 25% of dividend payers in the CN market (1.92%).
Future Dividend Coverage
Stable Dividend
Rewards
Trading at 36.5% below our estimate of its fair value
Earnings are forecast to grow 24.91% per year
Risks
Volatile share price over the past 3 months